# Georges Nakhoul

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/georges-nakhoul/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,338 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 18 |
| i10-index | 24 |
| Last Known Institution | Cleveland Clinic |
| OpenAlex ID | https://openalex.org/A5005480838 |
| ORCID iD | 0000-0002-8997-1940 |
| Works | 99 |

## Researcher papers

- [Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease](https://scholariq.org/papers/serum-potassium-end-stage-renal-disease-and-mortality-in-chronic-kidney-disease/)
- [Geographic Trends, Patient Characteristics, and Outcomes of Infective Endocarditis Associated With Drug Abuse in the United States From 2002 to 2016](https://scholariq.org/papers/geographic-trends-patient-characteristics-and-outcomes-of-infective-endocarditis/)
- [Therapeutic Advances in Diabetic Nephropathy](https://scholariq.org/papers/therapeutic-advances-in-diabetic-nephropathy/)
- [Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial](https://scholariq.org/papers/impact-of-primary-kidney-disease-on-the-effects-of-empagliflozin-in-patients/)
- [Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial](https://scholariq.org/papers/effects-of-empagliflozin-on-progression-of-chronic-kidney-disease-a-prespecified/)
- [Barriers to accessing essential medicines for kidney disease in low- and lower middle–income countries\|](https://scholariq.org/papers/barriers-to-accessing-essential-medicines-for-kidney-disease-in-low-and-lower/)
- [Anemia of chronic kidney disease: Treat it, but not too aggressively](https://scholariq.org/papers/anemia-of-chronic-kidney-disease-treat-it-but-not-too-aggressively/)
- [Off-clamp vs on-clamp robotic partial nephrectomy: Perioperative, functional and oncological outcomes from a propensity-score matching between two high-volume centers](https://scholariq.org/papers/off-clamp-vs-on-clamp-robotic-partial-nephrectomy-perioperative-functional-and/)
- [Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD](https://scholariq.org/papers/pragmatic-randomized-controlled-trial-of-patient-navigators-and-enhanced/)
- [Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease](https://scholariq.org/papers/mortality-outcomes-of-patients-with-chronic-kidney-disease-and-chronic/)
- [Clinical uptake of an antigen-based approach to membranous nephropathy: a survey of general nephrologists and glomerular disease experts](https://scholariq.org/papers/clinical-uptake-of-an-antigen-based-approach-to-membranous-nephropathy-a-survey/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Researcher university

- [Cleveland Clinic](https://scholariq.org/institutions/cleveland-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.